A randomized, double-blind phase 2b trial to evaluate efficacy of ChAd63-KH for treatment of post kala-azar dermal leishmaniasis

  1. Brima M. Younis
  2. Rebecca Wiggins
  3. Eltahir A.G. Khalil
  4. Mohamed Osman
  5. Francesco Santoro
  6. Chiara Sonnati
  7. Ada Keding
  8. Maria Novedrati
  9. Giorgio Montesi
  10. Ali Noureldein
  11. Elmukashfi T.A. Elmukashfi
  12. Ala Eldin Mustafa
  13. Mohammed Alamin
  14. Mohammed Saeed
  15. Khalid Salman
  16. Ahmed J. Suliman
  17. Amin E.A. Musa
  18. Alison M. Layton
  19. Charles J.N. Lacey
  20. Paul M. Kaye
  21. Ahmed M. Musa

Reviewed by

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1016/j.omtm.2024.101310
  2. Rapid Reviews Infectious Diseases

    David Diemert

    Review 2: "A Randomized Double-blind Phase IIb Trial to Evaluate the Efficacy of ChAd63-KH for the Treatment of Post Kala-azar Dermal Leishmaniasis"

    Overall, reviewers state that regardless of the negative results the study is well-performed and informative.

  3. Rapid Reviews Infectious Diseases

    Maria Agallou

    Review 1: "A Randomized Double-blind Phase IIb Trial to Evaluate the Efficacy of ChAd63-KH for the Treatment of Post Kala-azar Dermal Leishmaniasis"

    Overall, reviewers state that regardless of the negative results the study is well-performed and informative.

  5. Version published to 10.1101/2024.04.11.24305597 on medRxiv